Huntsville Hospital opposed Crestwood’s CON application on the grounds that there was no need for another angioplasty program in the community. Huntsville Hospital already has an angioplasty program as well as open-heart surgery capabilities, which Crestwood does not have. Earlier this year, a state-appointed administrative law judge recommended granting Crestwood a CON based on evidence that angioplasty can be performed safely at the hospital without open-heart surgery back-up.
As a condition for the CON, however, Crestwood is required to inform patients that they may need to be transported to a different hospital if a complication in the procedure results in the need for open-heart surgery.
Huntsville Hospital CEO David Spillers said the hospital is unlikely to appeal the CON decision, according to the report.
More Articles on Crestwood Medical Center:
Judge Recommends CON for Crestwood Medical Center in Alabama
Crestwood Medical Center, Huntsville Hospital in Alabama Bring Angioplasty Battle to Hearing
Alabama’s Crestwood, Huntsville Hospitals Continue Debate Over Angioplasty Plans
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
